Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: A prospective study

Stroke

Volumn 29, Issue 9, 1998, Pages 1810-1815

  Cullinane, Marisa ^a   Wainwright, Ray ^b   Brown, Angie ^b   Monaghan, Mark ^b   Markus, Hugh S ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Atrial fibrillation; Cerebral embolism; Cerebrovascular diseases; Ultrasonics

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BRAIN EMBOLISM; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ECHOENCEPHALOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; STROKE; SYMPTOMATOLOGY;

EID: 0031710287     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.9.1810     Document Type: Article

References (25)

1. Wolf PA, Abbott R, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
2. Warlow C. Non-rheumatic atrial fibrillation: warfarin or aspirin for all? Neurological comment. Br Heart J. 1992;68:647-648.
3. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomised controlled trials. Arch Intern Med. 1994;154:1449-1457.
4. Predictors of thromboembolism in atrial fibrillation, II: echocardiographic features of patients at risk. Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med. 1992;116:6-12.
5. Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk. Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med. 1992;116:1-5.
6. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet. 1989;1:175-179.
7. Russell D, Madden KP, Clark WM, Sandset PM, Zivin JA. Detection of arterial emboli using Doppler ultrasound in rabbits. Stroke. 1991;22: 253-258.
8. Markus HS, Brown MM. Differentiation between different pathological cerebral embolic materials using transcranial Doppler in an in vitro model. Stroke. 1993;24:1-5.
9. Markus H, Loh A, Brown MM. Detection of circulating cerebral emboli using Doppler ultrasound in a sheep model. J Neurol Sci. 1994;122: 117-124.
10. Siebler M, Sitzer M, Rose G, Bendfeldt D, Steinmetz H. Silent cerebral embolism caused by neurologically symptomatic high-grade carotid stenosis: event rates before and after carotid endarterectomy. Brain. 1993; 116:1005-1015.
11. Siebler M, Kleinschmidt A, Sitzer M, Steinmetz H, Freund H. Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Neurology. 1994;44:615-618.
12. Rams JJ, Davis AD, Lolley MD, Berger PM, Spencer MP. Detection of microemboli in patients with artificial heart valves using transcranial Doppler ultrasound: preliminary observations. J Heart Valve Dis. 1993; 2:37-41.
13. Georgiadis D, Grosset DG, Kelman A, Faichney A, Lees KR. Prevalence and characteristics of intracranial microemboli signals in patients with different types of prosthetic cardiac valves. Stroke. 1994;25:587-592.
14. Infeld B, Bowser DN, Gerraty RP, Voukelatos J, Grigg L, Mitchell PJ, Hopper JL, Davies SM. Cerebral microemboli in atrial fibrillation detected by transcranial Doppler ultrasonography. Cerebrovasc Dis. 1996;6:339-345.
15. Consensus Committee of the 9th International Cerebral Hemodynamic Symposium. Basic identification criteria of Doppler microembolic signals. Stroke. 1995;26:1123.
16. Markus HS, Molloy J. Use of a decibel threshold in detecting Doppler embolic signals. Stroke. 1997;28:692-695.
17. Markus H, Bland JM, Rose G, Sitzer M, Siebler M. How good is intercenter agreement in the identification of embolic signals in carotid artery disease? Stroke. 1996;27:1249-1252.
18. Grosset DG, Georgiadis D, Abdullah I, Bone I, Lees KR. Doppler emboli signals vary according to stroke subtype. Stroke. 1994;25:382-384.
19. Sliwka U, Job FP, Wissuwa D, Diehl RR, Flachskampf F, Hanrath P, Noth J. Occurrence of transcranial Doppler high-intensity transient signals in patients with potential cardiac sources of embolism: a prospective study. Stroke. 1995;26:2067-2070.
20. Tong DC, Albers GW. Transcranial Doppler-detected microemboli in patients with acute stroke. Stroke. 1995;26:1588-1592.
21. Tong DC, Bolger A, Albers GW. Incidence of transcranial Doppler-detected cerebral microemboli in patients referred for echocardiography. Stroke. 1994;25:2138-2141.
22. Orlandi G, Parenti G, Bertolucci A, Puglioli M, Collavoli P, Murri L. Carotid plaque features on angiography and asymptomatic cerebral microembolism. Acta Neurol Scand. 1997;96:183-186.
23. Sitzer M, Muller W, Siebler M, Hort W, Kniemeyer HW, Jancke L, Steinmetz H. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke. 1995;26:1231-1233.
24. Valton L, Larrue V, Arrue P, Geraud G, Bes A. Asymptomatic cerebral embolic signals in patients with carotid stenosis: correlation with the appearance of plaque ulceration on angiography. Stroke. 1995;26: 813-815.
25. Warlow CP, Dennis MS, Van Gijn J, Sandercock PAG, Bamford JM, Wardlaw J. What caused this transient or persisting ischaemic event? In: Stroke: A Practical Guide to Management. Oxford, UK: Blackwell Science; 1997.